Skip to content
Screener

Precigen PGEN Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Gilead Sciences logo
Gilead SciencesGILD
$4.75B+17.9%
Regenxbio logo
RegenxbioRGNX
$5.9M+214%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Allogene Therapeutics logo
Allogene TherapeuticsALLO
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.51B+388%
Enterprise value$2.6B+414%
P/S94.4×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Precigen’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017
(Amounts in thousands, except share data)March 31,2026December 31,2025
Total current assets101,672115,235
Long-term investments4892,511
Property, plant and equipment, net13,21913,758
Intangible assets, net2,8643,182
Goodwill15,23215,232
Right-of-use assets4,3694,679
Other assets782908
Total assets$138,627$155,505

Item 1. Condensed Consolidated Financial Statements

FAQ

What is Precigen's deferred tax assets and other non-current assets?
Precigen (PGEN) reported deferred tax assets and other non-current assets of $782K in Q1 2026.
How has Precigen's deferred tax assets and other non-current assets changed year-over-year?
Precigen's deferred tax assets and other non-current assets increased by 83.1% year-over-year, from $427K to $782K.
What is the long-term trend for Precigen's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Precigen's deferred tax assets and other non-current assets has grown at a -10.7% compound annual growth rate (CAGR), from $1.6M to $908K.

Ask your AI about Precigen's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude